Early Diabetes Intervention Program

Completed · Phase 4 · Has a placebo group

Conditions studied: Type 2 Diabetes Mellitus

In brief

This is an evaluation of the effect of acarbose to delay worsening of fasting glucose control in early Type 2 diabetes mellitus.

Key facts

Study ID

NCT01470937

Run by

Indiana University

People needed

219

Starts

1998-02-01

Expected to finish

2004-09-01

Last updated by the study team

2011-11-11

Who can join

Age: 25 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Fasting plasma glucose <140 mg/dL
• 75 g OGTT 2hr glucose >120 mg/dL
• BMI > 25 OR history of gestational diabetes mellitus OR family history of type 2 diabetes
• Age at least 25 years

You may not qualify if…

• Cancer within 5 years
• Chronic infectious disease (HIV, Hepatitis)
• CVD event within 6 months
• Uncontrolled hypertension or requiring beta blockers or thiazide diuretics for control
• elevated AST or ALT
• Serum creatinine >1.4 mg/dL (men) or >1.3 mg/dL (women)
• TG >600 mg/dL
• Known glucosidase intolerance
• Inability to comply with protocol requirements.

Where it is running

• Indiana University Hospital GCRC — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.